// App-Quantinova.ai

: Bosutinib protects against pulmonary vascular leakage by improving endothelial cell-matrix adhesion

Researchers

Presenter

  • Liza Botros

Principal Investigators

  • Manon Pronk

  • Jenny Juschten

  • John Liddle

  • Pieter Tuinman

  • Stephan Huveneers

  • Harm Jan Bogaard

  • Victor Van Hinsbergh

  • Peter Hordijk

  • Jurjan Aman

Medical Centers

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, Netherlands

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, Netherlands

  • Amsterdam UMC, University of Amsterdam, Department of Obstetrics, Amsterdam, Netherlands

  • GlaxoSmithKline, Stevenage, United Kingdom.

  • Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Amsterdam, the Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute lung injury

  • Pulmonary edema

Biomarkers

  • N/A

Drug/Treatment

  • Bosutinib

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved